WT1 Zinc Finger Domain as a Dominant Negative in Breast Cancer
Author Information
Author(s): Han Youqi, San-Marina Serban, Yang Lin, Khoury Haytham, Minden Mark D
Primary Institution: Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada
Hypothesis
The zinc finger domain of the Wilms' tumor 1 suppressor gene (WT1) can act as a dominant negative regulator in breast cancer cells.
Conclusion
The WT1–ZF plasmid acts as a dominant-negative regulator of WT1 in breast cancer cells, inhibiting cell proliferation and inducing apoptosis.
Supporting Evidence
- WT1–ZF significantly inhibited the transcriptional activation of c-myc.
- Stable expression of ZF - KTS reduced endogenous WT1 expression by 43% in MCF-7 cells.
- WT1–ZF - KTS induced apoptosis in breast cancer cells.
- Colony formation was reduced by 64% in MCF-7 cells expressing ZF - KTS.
Takeaway
Scientists found that a part of a gene called WT1 can stop breast cancer cells from growing and even make them die. This could help in creating new treatments for breast cancer.
Methodology
The study used luciferase assays, chromatin immunoprecipitation, and quantitative real-time PCR to assess the effects of WT1–ZF on gene expression and cell growth.
Limitations
The study primarily focused on specific breast cancer cell lines and may not generalize to all breast cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website